Detalles de la búsqueda
1.
Expression of CD44 is associated with aggressiveness in seminomas.
Mol Biol Rep
; 51(1): 693, 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38796656
2.
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Am J Hematol
; 98(5): 730-738, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869876
3.
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.
Am J Hematol
; 98(9): E226-E229, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340832
4.
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
J Clin Med
; 13(2)2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38276092
5.
High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients.
Front Med (Lausanne)
; 9: 845490, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35252277
6.
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.
Blood Cancer J
; 8(3): 31, 2018 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523783
Resultados
1 -
6
de 6
1
Próxima >
>>